Bisphosphonate-related osteonecrosis of the jaw in patients with oral bisphosphonate exposure: clinical course and outcomes. [electronic resource]
Producer: 20121024Description: 1844-53 p. digitalISSN:- 1531-5053
- Administration, Oral
- Aged
- Aged, 80 and over
- Alendronate -- administration & dosage
- Anti-Bacterial Agents -- therapeutic use
- Antirheumatic Agents -- therapeutic use
- Bisphosphonate-Associated Osteonecrosis of the Jaw -- etiology
- Bone Density Conservation Agents -- administration & dosage
- Bone Diseases, Metabolic -- drug therapy
- Chronic Disease
- Cohort Studies
- Debridement
- Diphosphonates -- administration & dosage
- Female
- Follow-Up Studies
- Glucocorticoids -- therapeutic use
- Humans
- Ibandronic Acid
- Male
- Middle Aged
- Osteolysis -- etiology
- Osteoporosis -- drug therapy
- Osteosclerosis -- etiology
- Retrospective Studies
- Tooth Extraction
- Treatment Outcome
- Wound Healing -- physiology
No physical items for this record
Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.